Some parts of the portal may cause error messages or display incorrectly due to the transition to a new provider of trading data

BNTCW - Benitec Biopharma Ltd Warrants 2015-14.8.20 on ADS

Previous close
0.0352
0   0%

Share volume: 0
Last Updated: Tue 14 Apr 2020 06:00:00 AM CEST
Biotechnology: -0.86%

PREVIOUS CLOSE
CHG
CHG%
$0.04
0.00
0.00%
This ticker is disabled and data are no longer maintained and up to date.
Overview Charts Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
59%
Profitability 75%
Dept financing 25%
Liquidity 0%
Performance 65%
Performance
5 Days
0   0%
1 Month
0   0%
3 Months
0   0%
6 Months
0   0%
1 Year
0   0%
2 Year
0   0%
Key data
Stock price
$0.04
P/E Ratio 
N/A
DAY RANGE
$0.04 - $0.04
EPS 
$0.00
52 WEEK RANGE
$0.11 - $0.85
52 WEEK CHANGE
-$56.41
MARKET CAP 
535.478 K
YIELD 
N/A
SHARES OUTSTANDING 
1.071 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
N/A
BETA 
0.00
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$5
AVERAGE 30 VOLUME 
$2
Company detail
CEO: Jerel A. Banks
Region: US
Website: http://www.benitec.com
Employees: 0
IPO year: -
Issue type:
Market: NASDAQ
Industry: Biotechnology
Sector: Health Technology

Benitec Biopharma Ltd. engages in the development of proprietary therapeutic technology platform. It focuses on chronic and life-threatening human disease areas such as oncology, orphan disease, retinal disease, and infectious disease. The company was founded in 1997 and is headquartered in North Sydney, Australia.

Recent news